Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BDNF inhibitors(Brain derived neurotrophic factor ligand inhibitors), NGF inhibitors(Nerve growth factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | SE | 23 Feb 2024 | |
Keratitis | Preclinical | SE | - |